Fesarius Therapeutics

About:

Fesarius Therapeutics is to develop engineered skin replacement products.

Website: https://www.fesariustherapeutics.com

Twitter/X: fesariustherapy

Top Investors: National Institutes of Health, New York Ventures, NIAMS

Description:

Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement products. To create a line of engineered tissue goods, developed a tissue engineering technique based on IP for microsphere-containing hydrogels. The company's method uses microspheres embedded in a collagen hydrogel to enhance the number of differential density interfaces that drive cell invasion into the scaffold, allowing patients to heal from trauma, burns, or infection at an affordable cost.

Total Funding Amount:

$2.63M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2015-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-08-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai